Volume 18 Number 2
June 2022

Volume 18 Number 2

In this issue there is a State-of-the-Art on the management of in-stent restenosis, the most common cause of stent failure after PCI today. A mini focus on drug-eluting stents (DES) and drug-coated balloons (DCB), with articles on polymer-free vs polymer DES from the SORT OUT IX trial; the BIOVITESSE study looking at the BIOrapid polymer-free coated coronary stent system which could be used with shorter DAPT; differences in coronary vasomotion between DES vs DCB. In coronary interventions: the impact of OCT use in determining suboptimal criteria for stent implantation from the CLI-OPCI registry. In valvular disease and heart failure: the challenge of cerebral embolisation during transcatheter edge-to-edge repair (TEER) of the mitral valve using the MitraClip system; employing the leaflet-to-annulus index to predicting residual tricuspid regurgitation after TEER; and more...

State of the art

State-of-the-Art Review
Management of in-stent restenosis
June 3, 2022 | 10.4244/EIJ-D-21-01034